Improved in vivo Experimental Screening Identifies an Anabolic Analog of 1,25 Dihydroxyvitamin D3 With Minimal Bone Resorption Activity

J Bone Miner Res. 2020 Apr;35(4):621-622. doi: 10.1002/jbmr.3933. Epub 2020 Jan 6.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Comment

MeSH terms

  • Animals
  • Bone Resorption* / drug therapy
  • Bone and Bones
  • Calcitriol*
  • Rats
  • Vitamin D

Substances

  • Vitamin D
  • Calcitriol